Funding Opportunities

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on new approaches for curative treatment or significant improvement of existing treatments for Hyper IgM Syndrome aimed at reducing mortality and morbidity and improving quality of life.

Sponsor: Hyper IgM Foundation

Application Due Date: 2023-06-15

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To support well-defined research projects that have a specified benefit for improving the treatment, health, disease management, or diagnosis of people with primary immunodeficiencies (PI).

Sponsor: Immune Deficiency Foundation (IDF)

Eligibility Criteria: Eligibility is limited to those currently residing in the US. IDF is encouraging investigators that have an interest in pursuing a career in primary immunodeficiencies to apply.

Application Due Date: 2023-02-28

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Promote discovery in the field resulting in new peer-reviewed publications and to generate preliminary data necessary to fuel the design and implementation of clinical trials with robust mechanistic studies

Sponsor: Primary Immune Deficiency Treatment Consortium

Eligibility Criteria: Must have an appointment as an independent faculty member, eligible to apply for NIH grant funding, at an eligible PIDTC center. Junior faculty (within 5 years of their appointment) are encouraged to apply.

Letter of Intent Due Date: 2022-03-18

Application Due Date: 2022-05-02

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The purpose of the award is to encourage research in primary immunodeficiencies, particularly related to treatment by, transplantation, gene therapy, or best available medical management.

Sponsor: Primary Immune Deficiency Treatment Consortium (PIDTC)

Eligibility Criteria: Trainees or Junior Faculty with two years or less as a faculty member. Prior recipients can compete to receive one additional year of continuous funding with a progress report documenting that headway has been made on the research topic as long as they are still eligible by trainee status. Underrepresented minority applicants specifically encouraged to apply.

Application Due Date: 2022-04-25

Term: One Year

Opportunity Type: Other

Goal: To address the persistent challenge to achieve earlier diagnosis and expanding and diversifying our community.

Sponsor: Immune Deficiency Foundation (IDF)

Eligibility Criteria: All individuals, institutions, schools, and researchers.

Application Due Date: 2022-02-28

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To improve long-term outcomes and/or reduce treatment related long-term complications, thereby improving quality of life post treatment and to find innovative approaches aimed at improving the diagnosis, the treatment, or maintaining the treatment continuity of Severe Combined Immune Deficiency (SCID) patients, within marginalized communities.

Sponsor: SCID Angels for Life Foundation

Eligibility Criteria: Eligible applicants should hold a Ph.D. or M.D degree. Applicants should be full-time permanent faculty members or post-doctoral fellows with a degree in fields related to SCID including, Immunology, Hematology, Cell Biology, Medicine, Biochemistry, Translational Research, or a similar field, at a research institute within the United States or Canada.

Application Due Date: 2021-12-15

Term: One Year